Q2 2024 Holdings
Filed 2024-08-14 | 26 holdings | $264.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $27.6M | 64,196 | 10.4% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $22.7M | 503,089 | 8.6% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $21.5M | 479,681 | 8.1% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $16.3M | 215,680 | 6.2% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $15.4M | 113,224 | 5.8% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $14.7M | 272,036 | 5.6% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $14.7M | 178,589 | 5.6% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $14.1M | 1,673,919 | 5.3% |
| Cargo Therapeutics Inc(CRGX) | COM | 14179K101 | $14.1M | 856,849 | 5.3% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $13.3M | 1,128,478 | 5.0% |
| Celcuity Inc(CELC) | COM | 15102K100 | $12.5M | 760,941 | 4.7% |
| Merus N V | COM | N5749R100 | $9.7M | 164,773 | 3.7% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $8.6M | 419,654 | 3.3% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $8.3M | 627,760 | 3.1% |
| Ironwood Pharmaceuticals Inc(IRWD) | COM CL A | 46333X108 | $7.3M | 1,113,824 | 2.7% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $7.1M | 713,536 | 2.7% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $6.3M | 249,609 | 2.4% |
| Phathom Pharmaceuticals Inc(PHAT) | COM | 71722W107 | $6.1M | 593,306 | 2.3% |
| Iteos Therapeutics Inc(5E7) | COM | 46565G104 | $5.5M | 367,429 | 2.1% |
| Inozyme Pharma Inc | COM | 45790W108 | $5.1M | 1,140,310 | 1.9% |
| Neumora Therapeutics Inc.(NMRA) | COM | 640979100 | $3.8M | 390,084 | 1.4% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $3.6M | 152,178 | 1.3% |
| Longboard Pharmaceuticals in | COM | 54300N103 | $1.9M | 71,442 | 0.7% |
| Rapport Therapeutics Inc(RAPP) | COM | 75383L102 | $1.6M | 70,000 | 0.6% |
| Morphic Hldg Inc | COM | 61775R105 | $1.6M | 47,660 | 0.6% |
| Contineum Therapeutics Inc(CTNM) | CL A | 21217B100 | $1.3M | 72,831 | 0.5% |